Breast Cancer Survivor
Conditions
Keywords
Motor imagery, Action observation
Brief summary
The aim of this study is to evaluate the effectivity of the combined motor imagery and action observation therapies to improve functional parameters such as strenght, range of motion, pain or fear of movements among others in relation to upper limb in breast cancer survivors. The main question it aims to answer is: Will a combined therapy of motor imagery and action observation improve the strenght, rang of motion, pain, limb diameter and fear of movement of the upper limb in breast cancer survivor females? The participants will be part of the IM-OA23 proyect that consist on seeing some diferent videos about upper limb mobility and then they'll have to imagine the movements and to performed themselves. Researches will compare two groups (control group and intervention group) to evaluate the diferences between them.
Detailed description
Purpose: The aim of this study is to evaluate the effectivity of a combined motor imagery and action observation protocol at strength, range of motion, limb diamter, and fear of movement of the upper limb of breast cancer survivors. Methods: A randomised controlled clinical trial will be conducted. Subjects will be randomly assigned to the two randomly assigned to the two treatment groups: intervention (IM-OA23 programme) and control group (usual care). This study will have pre and post measurements. The intervention consist on a display of diferent videos of upper limb movements and at daily living activities and in a excercise of imagine and doing this movements. The're will be used diferent tools such as a dynamometer, a goniometer, Visual Analogue Scale (VAS) of pain, or TSK questionnaire.
Interventions
OTHERMotor imagery combined with action observation
To observe and imaging one action with a video resource. Not virtual reality.
Sponsors
Instituto de Investigación Sanitaria de Navarra (IdiSNA)
Fundacion Miguel Servet
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Female, over 18 years, have suffered breast cancer, have ended active treatments (chemotherapy, radiotherapy, surgery), have pain or functional limitation or lymphedema at upper limb afected.
Exclusion criteria
* males, people with active treatments ongoning, other types of cancer, recurrence or metastasis of cancer
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Imagery | From enrollement to the end of the treatment at 6 weeks and 3 month after | Imagery will be assessed using the Movement Imagery Questionnaire revised second edition (MIQ-RS) |
| Sthrength | From enrollement to the end of the treatment at 6 weeks and 3 month after | The grip strength of the hand of the affected limb shall be studied, using a dynamometer. |
| Range of Motion | From enrollement to the end of the treatment at 6 weeks and 3 month after | The measurement of the degrees of movement of the shoulder joint by means of a goniometer. The movements of flexion, abduction and internal and external rotation shall be studied using previously established reference points. external rotation, using previously established reference points |
| Pain intensity | From enrollement to the end of the treatment at 6 weeks and 3 month after | Pain intensity will be measured by Visual Analogue Scale (VAS). Participants will have to score their pain on a range from 0 to 10 where 0 means no pain at all and 10 my pain is as bas as it could possibly be. |
| Limb diameter | From enrollement to the end of the treatment at 6 weeks and 3 month after | Limb diameter will be measured by a measuring tape. The measurement is taken at the midpoint between the acromion and the olecranon, the tape being perpendicular to the limb without compressing the area. The midpoint is located with an elbow flexion of 90 degrees and then the measurement is taken with the elbow in extension, the result is expressed in centimetres. |
| Fear of movement | From enrollement to the end of the treatment at 6 weeks and 3 month after | Fear of movement will be measured by the TSK questionnaire |
Countries
Spain
Contacts
Primary ContactPilar Arnal-Vallés, Candidate PhD
Outcome results
None listed